Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, October 31, 2022
[ Mon, Oct 31st 2022
] - WOPRAI
[ Mon, Oct 31st 2022
] - WOPRAI
[ Mon, Oct 31st 2022
] - WOPRAI
[ Mon, Oct 31st 2022
] - WOPRAI
[ Mon, Oct 31st 2022
] - WOPRAI
[ Mon, Oct 31st 2022
] - WOPRAI
[ Mon, Oct 31st 2022
] - WOPRAI
[ Mon, Oct 31st 2022
] - WOPRAI
[ Mon, Oct 31st 2022
] - WOPRAI
[ Mon, Oct 31st 2022
] - WOPRAI
[ Mon, Oct 31st 2022
] - WOPRAI
[ Mon, Oct 31st 2022
] - WOPRAI
[ Mon, Oct 31st 2022
] - WOPRAI
[ Mon, Oct 31st 2022
] - WOPRAI
[ Mon, Oct 31st 2022
] - WOPRAI
[ Mon, Oct 31st 2022
] - WOPRAI
[ Mon, Oct 31st 2022
] - WOPRAI
[ Mon, Oct 31st 2022
] - WOPRAI
[ Mon, Oct 31st 2022
] - WOPRAI
[ Mon, Oct 31st 2022
] - WOPRAI
[ Mon, Oct 31st 2022
] - WOPRAI
[ Mon, Oct 31st 2022
] - WOPRAI
[ Mon, Oct 31st 2022
] - WOPRAI
[ Mon, Oct 31st 2022
] - WOPRAI
[ Mon, Oct 31st 2022
] - WOPRAI
[ Mon, Oct 31st 2022
] - WOPRAI
[ Mon, Oct 31st 2022
] - WOPRAI
[ Mon, Oct 31st 2022
] - WOPRAI
[ Mon, Oct 31st 2022
] - WOPRAI
Tessa Romero Downgraded (YMAB) to Sell and Decreased Target to $7 on, Oct 31st, 2022
Tessa Romero of JP Morgan, Downgraded "Y-mAbs Therapeutics, Inc." (YMAB) to Sell and Decreased Target from $16 to $7 on, Oct 31st, 2022.
Tessa, nor any peers, have made any analyst calls on YMAB in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30